Ebola vaccine: ‘In an outbreak situation we’re racing against time’

Efforts to develop a vaccine against the current Ebola outbreak in the Democratic Republic of Congo (DRC) have already achieved initial successes thanks to an innovative funding strategy. With no approved vaccine or treatment available for the Bundibugyo strain of Ebola, the outbreak in the Democratic Republic of Congo

Glasgow researchers will test whether an existing Ebola vaccine could offer protection against Bundibugyo amid the escalating DRC outbreak.

Glasgow researchers will test whether an existing Ebola vaccine could offer protection against Bundibugyo amid the escalating DRC outbreak.

BUNIA, Congo (AP) -- Congo has received more than 16,000 doses of the Ervebo vaccine as the country grapples with the fastest Ebola outbreak in histor

The current outbreak in the Democratic Republic of the Congo has been caused by the rare Bundibugyo virus, which has no current treatment or vaccine - it can spread easily and go undetected

The Democratic Republic of Congo has received more than 16,000 doses of an Ebola vaccine, as authorities step up efforts against the ongoing outbreak. More than 2,500 people have already died and health officials from the WHO are warning this epidemic could surpass the deadliest on record – that occurred between 2014 a

Prostate cancer therapy, Meta glasses in hospital settings, and more health news from Morning Rounds

DRC receives 70,000 Ervebo vaccine doses, with 20,000 for a Phase III trial against Bundibugyo virus and 50,000 for frontline and health workers.

By Chioma Obinna The Democratic Republic of the Congo, DRC, has secured an initial 70,000 doses of Ervebo vaccine from the global Ebola vaccine stockpile as health authorities intensify efforts to contain the ongoing Bundibugyo virus disease outbreak. The release followed a request by the DRC government to the Internat

WHO experts say early evidence, including animal studies, suggests Ervebo could offer some protection—and the new trial will seek to establish whether that protection extends to humans.